Alcoa
Alcoa has recently been added to our ASX 200 investor model portfolio.
XJO & Market Direction
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
S&P500 & Market Direction
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
There are new Signals.
For our Members, please find below the latest list of signals.
US Earnings
Monday, February 3 – Palantir Technologies, NXP Semiconductors, IDEXX Laboratories, Tyson Foods, and Clorox.
Tuesday, February 4 – Alphabet, Merck, PepsiCo, Advanced Micro Devices, and Amgen.
Wednesday, February 5 – Novo Nordisk, Walt Disney, Qualcomm, Arm Holdings, and Uber Technologies.
Thursday, February 6 – Eli Lilly, Linde, Honeywell International, ConocoPhillips, Neurocrine Biosciences, and Bristol-Myers Squibb.
February 7 – Fortive, Cboe Global Markets, Banco Bradesco, and Kimco Realty.
Apple Inc: Q1 Earnings
Apple Inc. – Common is under Algo Engine sell conditions.
Q1 2025 earnings: $124.3 billion in total revenue, YoY a 3.95% increase. Products increased by 1.56% YoY to $97.96 billion, while services grew by 13.94% YoY to $26.34 billion.
Apple increased its gross profit by 6.23% YoY to $58.28 billion. On the bottom line, AAPL generated $36.33 billion of net income, a YoY increase of 7.12%, and EPS increased by 13.73% or $2.41 per share.
There are new Signals.
For our Members, please find below the latest list of signals.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.